Although it is not a cure for the disease, intravenously administered every 2 weeks, the drug has been shown to have moderately positive effects in clinical trials.

Although it is not a cure for the disease, intravenously administered every 2 weeks, the drug has been shown to have moderately positive effects in clinical trials.